TNF and rheumatoid arthritis: TNF-α inhibitors used as disease-modifying agents in RA improve not only the clinical symptoms of RA, but also decrease the associated vascular risk (335), suggesting that a stratified biologic approach may be of use to therapeutically dampen chronic systemic inflammation related to aging and other age-related diseases.